Axon Enterprise
AXON
$311.85
Share price
1.17%
Change (1 day)
48.00%
Change (1 year)
Operating Margin for Axon Enterprise (AXON)
Operating Margin as of April 2024 (TTM): 8.16%
According to Axon Enterprise 's latest financial reports and stock price the company's current Operating Margin is 8.16%. At the end of 2022 the company had an Operating Margin of 16.52%.
Operating Margin history for Axon Enterprise from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 16.52% | -200.86% |
| 2021 | -16.37% | 1672.55% |
| 2020 | -0.92% | -336.91% |
| 2019 | 0.39% | -94.17% |
| 2018 | 6.69% | 45.94% |
| 2017 | 4.58% | -60.96% |
| 2016 | 11.74% | -34.29% |
| 2015 | 17.87% | -9.01% |
| 2014 | 19.64% | -11.49% |
| 2013 | 22.19% | 12.61% |
| 2012 | 19.70% | -275.68% |
| 2011 | -11.22% | 90.66% |
| 2010 | -5.88% | -6811.82% |
| 2009 | 0.09% | -98.83% |
| 2008 | 7.48% | -66.56% |
| 2007 | 22.36% | -403.84% |
| 2006 | -7.36% | -229.25% |
| 2005 | 5.69% | -87.7% |
| 2004 | 46.30% | 53.68% |
| 2003 | 30.13% | 678.78% |
| 2002 | 3.87% | -57.24% |
| 2001 | 9.05% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 XBiotech XBIT | -860.09% | -10,640.32% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | -160.78% | -2,070.34% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | -79.07% | -1,069.02% | 🇺🇸 USA |
 Exelixis EXEL | 11.86% | 45.34% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.